You just read:

Geom Therapeutics to Develop and Commercialize LegoChem Biosciences' Novel Beta Lactamase Inhibitors For Treating Gram-Negative Infections

News provided by

Geom Therapeutics, Inc.

Sep 27, 2017, 08:00 ET